Traumatic Brain Injuries Assessment Market Size & Share, By Product (Screening devices, Monitoring devices); End use - Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2025-2037

  • Report ID: 6689
  • Published Date: Nov 14, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Traumatic Brain Injuries Assessment Market size was estimated at USD 3.4 billion in 2024 and is expected to surpass USD 8.2 billion by the end of 2037, rising at a CAGR of 7.7% during the forecast period, i.e., 2025-2037. In 2025, the industry size of traumatic brain injuries assessment is evaluated at USD 3.6 billion.

Traumatic brain injury (TBI) has emerged as a prominent neurological disorder, leading to a significant public health burden and raising the risk of developing late-onset neurodegeneration.   According to a 2024 report by the Center for Disease Control and Prevention (CDC), in the U.S. deaths related to TBI were 69,000 in 2021 which means approx. 190 TBI-related deaths day-to-day. Similarly, in April 2024, the American Association of Neurological Surgeons (AANS) projected that 1.7 to 3.8 million TBIs arise yearly in the U.S. due to recreational and sports activities accounting for 10% of these cases. Globally, over 55 million individuals experience mild TBI and 5.48 million suffer from severe TBI every year. The alarming rise in TBI cases has driven the adoption of TBI assessment solutions.


Traumatic Brain Injuries Assessment Market
Get more information on this report: Request Free Sample PDF

Traumatic Brain Injuries Assessment Sector: Growth Drivers and Challenges

Growth Drivers

  • Developments in medical technology: Ongoing advancements in technology such as screening devices including computerized tomography (CT) scan, magnetic resonance imaging (MRI), and biomarker identification have enhanced the speed, accuracy, and convenience of TBI assessments. These technological developments enable healthcare professionals to diagnose TBIs more effectively which leads to better patient results and driving traumatic brain injuries assessment market growth. For example, In January 2024, the Wyss Institute for Biologically Inspired Engineering at Harvard University introduced a new brain imaging technique that allows the identification of mild traumatic brain injuries (mTBIs), otherwise undetectable by conventional techniques.

    Numerous TBIs can be treated with minimally invasive procedures such as ultrasound, MRI or CT scanning, and endoscopy to remove contusions that have formed from brain injury.  In March 2022, the Swoop Portable MR Imaging system was developed by UC Davis Health and Connecticut-based Hyperfine. It is the first portable MRI device approved by the Food and Drug Administration (FDA) and is designed to decrease the time for diagnosing traumatic brain injuries.
  • Rise in campaigns and government initiatives to spread awareness about TBI: The rising number of campaigns and initiatives being undertaken by the governments of several countries about brain injuries are projected to fuel the traumatic brain injuries assessment market growth. The Brain Injury Association of America (BIAA) is focused on promoting public awareness through campaigns and initiatives to effectively treat TBIs and organizes a national public awareness campaign in March each year to highlight the importance of admitting the impact of brain injuries. For instance, in February 2024, BIAA announced a new awareness campaign in combination with brain injury awareness to involve and educate the general public.

    In November 2020, the decision-making body of WHO- the World Health Assembly passed resolution WHA73.10 and in 2021 it introduced the Decade for Action on Road Safety plan for global awareness of the treatment and assessment of neurological disorders. Ongoing observational studies conducted under the International Traumatic Brain Injury Research (InTBIR) initiative umbrella are pushing market adoption.

Challenges

  • Complexity in classification and TBI diagnosis: TBIs vary widely in severity and can present with delayed or subtle symptoms while making diagnosis challenging assessing the extent of brain injury needs specialized equipment, training, and understanding of complex neurological data. This complexity can lead to under-diagnosis or misdiagnosis of TBIs particularly in mild cases by impacting patient outcomes.
  • Ethical and regulatory concerns: Traumatic brain injury diagnostic devices particularly those involving data collection on brain function and neuroimaging face rigorous regulatory inspection. Compliance with strict healthcare regulations, ethical standards, and data privacy law can slow the approval and market entry of new TBI assessment innovations while increasing time to traumatic brain injuries assessment market and restricting modernization in certain regions.

Traumatic Brain Injuries Assessment Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

7.7%

Base Year Market Size (2024)

USD 3.4 billion

Forecast Year Market Size (2037)

USD 8.2 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Traumatic Brain Injuries Assessment Segmentation

Product (Screening devices, Monitoring devices)

Screening devices segment is expected to dominate around 80.4% traumatic brain injuries assessment market share by the end of 2037. Developments in technology have led to the progress of more accurate and sophisticated screening devices for TBIs. Innovations such as handheld devices, portable neuroimaging tools, and advanced algorithms improve the ability to detect and assess brain injuries more effectively and drive the traumatic brain injuries assessment market for these devices which leads to segmental growth.

For example, in March 2022, Swift Medical Inc. announced the Swift Ray 1, an advanced hardware device that can be connected wirelessly to a smartphone camera. This device transforms the field of wound care expertise by capturing comprehensive clinical data, which greatly enhances the assessment and monitoring of the treatment of wounds and other skin conditions. The Swift Ray 1 is designed to be compact, and easily suitable in the palm of a clinician or patient's hand, permitting portable and convenient medical imaging.

Screening devices empower healthcare professionals to access powerful imaging capabilities at any place, from the hospital setting to the ease of a patient's home. This can be attributed to the minimally invasive nature of these devices and growing awareness and developments in healthcare facilities. Moreover, factors, such as better accuracy of these devices, growing patient preference for non-invasive procedures, and an increasing preference among physicians for brain disease progression monitoring, are projected to drive the growth of this segment throughout the forecast period.

End use (Hospitals, Diagnostic centers, Other end users)

The hospital segment is projected to have a faster-growing traumatic brain injuries assessment market share during the forecast period of 2025-2037. Hospitals are often the first point of care for TBI patients. Hospital admissions are also driven by the rising number of brain surgeries across the world. The rise in the number of hospitals improves access to progressive treatment and diagnostic facilities for TBIs by safeguarding timely and accurate assessment. This growth supports the availability of multidisciplinary teams and specialized care while improving patient results and driving traumatic brain injuries assessment market growth.

Our in-depth analysis of the global market includes the following segments:

Product

  • Screening devices
  • Monitoring devices

End use

  • Hospitals
  • Diagnostic centers
  • Other end users

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Traumatic Brain Injuries Assessment Industry - Regional Scope

North America Market Analysis

North America in traumatic brain injuries assessment market is anticipated to dominate over 47.5% revenue share by 2037, due to the rising government initiatives, the existence of well-established healthcare facilities, awareness campaigns concerning brain injuries, and more incidence of TBIs in this region. The adoption of cutting-edge diagnostic tools and the accessibility of sophisticated medical facilities support the growth of the traumatic brain injuries assessment market.

Moreover, the region is a hub for technological advancement in medical devices. Constant developments in portable diagnostic devices, neuroimaging, and biomarker-based diagnostics have enhanced the efficiency and accuracy of TBI assessments. The adoption of these innovative technologies drives traumatic brain injuries assessment market growth. For example, in February 2024, the University of Birmingham, in the U.S. developed an advanced diagnostic device for the fast detection of TBI. This innovative technology employs a safe laser directed into the eye providing a distinct method for diagnosing TBI.

Canada healthcare system continues to offer comprehensive care for TBI patients, surgical inventions, encompasses emergency response, rehabilitation services, and support. Ongoing research and development efforts are focused on enhancing the quality of life and improving treatment results for individuals affected by TBI.

Asia Pacific Market Analysis

Asia Pacific is expected to experience a stable CAGR during the forecast period due to an increase in the incidence of road accidents and violence. Additionally, the country’s innovative healthcare infrastructure supports the adoption of cutting-edge medical technologies. The availability of state-of-the-art equipment in hospitals and clinics as well as high standards of medical care contributes to the growth of the market.

Japan holds a leading position in the Asia Pacific traumatic brain injuries assessment market. It has one of the world’s fastest-aging populations. The rising number of older adults surges the demand for effective TBI assessment tools to manage and diagnose brain injuries in this demographic.

Increase in the number of people suffering from TBIs in India due to growing incidence of road accidents, and violence. For example, in 2021, according to the Ministry of Road Transport and Highways, Government of India, a total of 4,12,432 road accidents in 2021 caused injuries to 3,84,448 individuals. Also, rising patient affordability has resulted in a substantial number of interventional procedures in the country.

Research Nester
Traumatic Brain Injuries Assessment Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Traumatic Brain Injuries Assessment Landscape

    The traumatic brain injuries assessment market is growing by various players which are driving the growth through innovative technologies, advancements in diagnostic tools, and partnerships with healthcare providers. Some top leading players are Abbott Laboratories, BrainScope, Inc., and InfraScan, Inc. which are focusing on developing accurate and rapid TBI diagnostic solutions which are important in emergency settings. Here are some leading players in the traumatic brain injuries assessment market:

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • BrainScope, Inc.
    • Oculogica
    • Raumedic AG
    • Koninklijke Philips N.V.
    • InfraScan, Inc.
    • Natus Medical, Inc.

In the News

  • In October 2024, Roche and the U.S. Biomedical Advanced Research and Development Authority (BARDA) Burn and Blast Medical Countermeasures Program, collaborated to expedite innovation around traumatic brain injuries.
  • In February 2024, Philips and Synthetic MR announced Smart Quant Neuro 3D, an innovative tool aimed at improving objective decision support in diagnosing and treating brain disorders such as TBI, multiple sclerosis (MS), and dementia. This partnership signifies a significant development in neuroimaging technology, promising to improve diagnostic precision and treatment efficiency for patients with complex neurological conditions.
  • In March 2023, Abbott received US Food and Drug Administration clearance for the first commercially available laboratory TBI blood test, making it widely available to hospitals in the United States. The test, which runs on Abbott's Alinity I laboratory instrument, provides clinicians with an objective way to rapidly assess individuals with mild TBIs, also known as concussions.
  • In March 2022, Oculogica launched the new EyeBOX device, battery-operated, lightweight, and small enough to fit in a backpack which makes it easy to use in both sports and clinical settings. This development benefited the company by improving the usability and portability of its product, thereby broadening its market reach and growing its appeal to a wider range of healthcare providers and sports organizations.

Author Credits:  Radhika Pawar


  • Report ID: 6689
  • Published Date: Nov 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The traumatic brain injuries assessment market size was USD 3.4 billion in 2024.

The global traumatic brain injuries assessment market size was USD 3.4 billion in 2024 and is likely to reach USD 8.2 billion by the end of 2037, expanding at a CAGR of 7.7% over the forecast period, i.e., 2025-2037.

Abbott Laboratories, BrainScope, Inc., Oculogica, Raumedic AG, Koninklijke Philips N.V., InfraScan, Inc., and Natus Medical, Inc. are some key players in the market.

The screening devices segment is expected to hold a leading share during the forecast period.

North America is projected to offer lucrative prospects with a share of 47.5% in 2037.
Traumatic Brain Injuries Assessment Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample